
Advanced Biomed Inc. Common Stock
ADVBNASDAQHealthcare● Active
$3.94
$-0.23(-5.52%)
Market Cap$4263557
P/E Ratio—
52W High$19.72
52W Low$3.61
Advanced Biomed Inc. Common Stock (ADVB) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ADVB · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Operations | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Advanced Biomed Inc. Common Stock data
About Advanced Biomed Inc. Common Stock (ADVB) Cash Flow Statement
Advanced Biomed Inc. Common Stock generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).
Frequently asked questions
ADVB · 4 questionsAdvanced Biomed Inc. Common Stock generated free cash flow of ($0.00B) for 2025, up 91.7% year-over-year.
ADVB free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10